应用

选项
视图 列表 网格

显示第112个,产品总数27

设置降序方向
  1. Recombinant Human Siglec-2/CD22 Protein
    • 种属: 人(Human)
    • Accession #: P20273
    • 表达系统: HEK293
    • 蛋白标签: C-His
    • 内毒素水平: <1.0 EU/μg
    • 生物活性: Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind Inotuzumab (anti-CD22) (Ab176429) with the EC50 of 20.1 ng/mL.  Immobilized Recombinant Human Siglec-2/CD22 Protein (rp169575) at 1.0 μg/mL can bind bind Epratuzumab (anti-CD22) (Ab175532) with the EC50 of 207.0 ng/mL.
  2. Recombinant Human Glypican 3 Protein
    • 种属: 人(Human)
    • Accession #: P51654-1
    • 表达系统: HEK293
    • 蛋白标签: C-His
    • 内毒素水平: <1.0 EU/μg
    • 生物活性: Immobilized Recombinant Human Glypican 3 Protein (rp176299) at 4.0 μg/mL can bind Recombinant Human FGF basic Protein (rp156010) with the EC50 of 441.4 ng/mL. Immobilized Recombinant Human FGF basic Protein (rp156010) at 1.0 μg/mL can bind Recombinant Human Glypican 3 Protein (rp176299) with the EC50 of 7.4 ng/mL.
  3. Recombinant Human ErbB3/HER3 Protein
    • 种属: 人(Human)
    • Accession #: P21860
    • 表达系统: HEK293
    • 蛋白标签: C-His
    • 内毒素水平: <1.0 EU/μg
    • 生物活性: Immobilized Recombinant Human ErbB3 / HER3 Protein (rp170123) at 1.0 μg/mL can bind Barecetamab (anti-ERBB3) (Ab182928) with the EC50 of 14.55 ng/mL. Immobilized Recombinant Human ErbB3 / HER3 Protein (rp170123) at 1.0 μg/mL can bind Lumretuzumab (anti-ERBB3) (Ab182754) with the EC50 of 31.62 ng/mL. Immobilized Recombinant Human ErbB3 / HER3 Protein (rp170123) at 1.0 μg/mL can bind Seribantumab (anti-ERBB3) (Ab175653) with the EC50 of 17.20 ng/mL. Immobilized Recombinant Human ErbB3 / HER3 Protein (rp170123) at 1.0 μg/mL can bind Patritumab (anti-ERBB3) (Ab170705) with the EC50 of 27.08 ng/mL.
  4. Recombinant Human CD79B Protein
    • 种属: 人(Human)
    • Accession #: P40259
    • 表达系统: HEK293
    • 蛋白标签: C-His
    • 内毒素水平: <1.0 EU/μg
    • 生物活性: 1. Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab (anti-CD79b) (Ab175715) with the EC50 of 11.08 ng/mL. 2. Immobilized Recombinant Human CD79B Protein (rp176729) at 1.0 μg/mL can bind Polatuzumab vedotin-piiq (anti-CD79b) (Ab175635) with the EC50 of 51.95 ng/mL.
  5. Recombinant Human OX40/TNFRSF4 Protein
    • 种属: 人(Human)
    • Accession #: P43489
    • 表达系统: HEK293
    • 蛋白标签: C-His
    • 内毒素水平: <1.0 EU/μg
    • 生物活性: Immobilized Recombinant Human OX40/TNFRSF4 Protein (rp181285) at 1.0 μg/mL can bind BMS-986178 (anti-CD134) (Ab209739) with the EC50 of 38.0 ng/mL.         Immobilized Recombinant Human OX40/TNFRSF4 Protein (rp181285) at 1.0 μg/mL can bind Ivuxolimab (anti-CD134) (Ab182815) with the EC50 of 32.7 ng/mL. Immobilized Recombinant Human OX40/TNFRSF4 Protein (rp181285) at 1.0 μg/mL can bind Tavolixizumab (anti-CD134) (Ab182830) with the EC50 of 41.2 ng/mL. Immobilized Recombinant Human OX40/TNFRSF4 Protein (rp181285) at 1.0 μg/mL can bind Cudarolimab (anti-CD134) (Ab182885) with the EC50 of 112.0 ng/mL.
页面
每页